Previous close | 0.1500 |
Open | 0.1100 |
Bid | 0.0200 |
Ask | 0.0400 |
Strike | 87.50 |
Expiry date | 2022-06-17 |
Day's range | 0.1100 - 0.1500 |
Contract range | N/A |
Volume | |
Open interest | 1.92k |
Vertex's (VRTX) cystic franchise sales continue to grow. Vertex has a broad clinical non-CF pipeline, which is progressing rapidly.
Yahoo Finance's Jared Blikre breaks down the stocks Warren Buffett's Berkshire Hathaway is buying and selling.
Pharma giant AbbVie (NYSE: ABBV) has rewarded shareholders in the past decade with market-beating performance. AbbVie's strong showing was primarily a result of its top-selling drug, Humira. If the company manages to replace the medicine, it could deliver many more years of solid performances.